The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cabergoline Market Research Report 2021

Global Cabergoline Market Research Report 2021

Publishing Date : Feb, 2021

License Type :
 

Report Code : 1603013

No of Pages : 94

Synopsis
Cabergoline is used to treat hyperprolactinemia (high levels of prolactin, a natural substance that helps breast-feeding women produce milk but can cause symptoms such as infertility, sexual problems, and bone loss in women who are not breast-feeding or men).

Europe has the largest global export quantity and manufacturers in Cabergoline market, while the North America is the second sales volume market for Cabergoline in 2019. In the industry, Teva API profits most in 2019 and recent years, and the gap of market share is keep on enlarged due to different strategy.

The global Cabergoline market was valued at US$ 7 million in 2019 and is expected to reach US$ 9 million by the end of 2026, growing at a CAGR of 4.8% during 2021-2026.

This report focuses on Cabergoline volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cabergoline market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Cabergoline Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Purity < 95%
  • Purity 95%-98%
  • Purity > 98%

Purity 95%-98% is the main type for Cabergoline, and the Purity 95%-98% reached a sales volume of approximately 55.40 Kg in 2019, with 49.63% of global sales volume.

Segment by Application

  • Anti-Parkinson
  • Hyperprolactinemic Disorders
  • Others

Hyperprolactinemic Disorders is the most widely used area which took up about 71% of the global total sales in 2019.

By Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • Teva API
  • Finetech Pharma
  • Global Biologicals
  • Wellona Pharma
  • Alven Laboratories
  • Salvavidas Pharmaceutical

Scope of the Cabergoline Market Report

Report Metric

Details

Report Name

Cabergoline Market

Market size in 2019

US$ 7 Million

The revenue forecast in 2026

US$ 9 Million

Growth Rate

CAGR of 4.8% from 2021 to 2026

Market size available for years

2019-2026

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Cabergoline Market Overview
1.1 Product Overview and Scope of Cabergoline
1.2 Cabergoline Segment by Type
1.2.1 Global Cabergoline Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Purity < 95%
1.2.3 Purity 95%-98%
1.2.4 Purity > 98%
1.3 Cabergoline Segment by Application
1.3.1 Cabergoline Sales Comparison by Application: (2021-2027)
1.3.2 Anti-Parkinson
1.3.3 Hyperprolactinemic Disorders
1.3.4 Others
1.4 Global Cabergoline Market Size Estimates and Forecasts
1.4.1 Global Cabergoline Revenue 2016-2027
1.4.2 Global Cabergoline Sales 2016-2027
1.4.3 Cabergoline Market Size by Region: 2016 Versus 2021 Versus 2027

2 Cabergoline Market Competition by Manufacturers
2.1 Global Cabergoline Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cabergoline Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cabergoline Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cabergoline Manufacturing Sites, Area Served, Product Type
2.5 Cabergoline Market Competitive Situation and Trends
2.5.1 Cabergoline Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cabergoline Players Market Share by Revenue
2.5.3 Global Cabergoline Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cabergoline Retrospective Market Scenario by Region
3.1 Global Cabergoline Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Cabergoline Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Cabergoline Market Facts & Figures by Country
3.3.1 North America Cabergoline Sales by Country
3.3.2 North America Cabergoline Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cabergoline Market Facts & Figures by Country
3.4.1 Europe Cabergoline Sales by Country
3.4.2 Europe Cabergoline Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cabergoline Market Facts & Figures by Region
3.5.1 Asia Pacific Cabergoline Sales by Region
3.5.2 Asia Pacific Cabergoline Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cabergoline Market Facts & Figures by Country
3.6.1 Latin America Cabergoline Sales by Country
3.6.2 Latin America Cabergoline Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cabergoline Market Facts & Figures by Country
3.7.1 Middle East and Africa Cabergoline Sales by Country
3.7.2 Middle East and Africa Cabergoline Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cabergoline Historic Market Analysis by Type
4.1 Global Cabergoline Sales Market Share by Type (2016-2021)
4.2 Global Cabergoline Revenue Market Share by Type (2016-2021)
4.3 Global Cabergoline Price by Type (2016-2021)

5 Global Cabergoline Historic Market Analysis by Application
5.1 Global Cabergoline Sales Market Share by Application (2016-2021)
5.2 Global Cabergoline Revenue Market Share by Application (2016-2021)
5.3 Global Cabergoline Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Teva API
6.1.1 Teva API Corporation Information
6.1.2 Teva API Description and Business Overview
6.1.3 Teva API Cabergoline Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Teva API Product Portfolio
6.1.5 Teva API Recent Developments/Updates
6.2 Finetech Pharma
6.2.1 Finetech Pharma Corporation Information
6.2.2 Finetech Pharma Description and Business Overview
6.2.3 Finetech Pharma Cabergoline Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Finetech Pharma Product Portfolio
6.2.5 Finetech Pharma Recent Developments/Updates
6.3 Global Biologicals
6.3.1 Global Biologicals Corporation Information
6.3.2 Global Biologicals Description and Business Overview
6.3.3 Global Biologicals Cabergoline Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Global Biologicals Product Portfolio
6.3.5 Global Biologicals Recent Developments/Updates
6.4 Wellona Pharma
6.4.1 Wellona Pharma Corporation Information
6.4.2 Wellona Pharma Description and Business Overview
6.4.3 Wellona Pharma Cabergoline Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Wellona Pharma Product Portfolio
6.4.5 Wellona Pharma Recent Developments/Updates
6.5 Alven Laboratories
6.5.1 Alven Laboratories Corporation Information
6.5.2 Alven Laboratories Description and Business Overview
6.5.3 Alven Laboratories Cabergoline Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Alven Laboratories Product Portfolio
6.5.5 Alven Laboratories Recent Developments/Updates
6.6 Salvavidas Pharmaceutical
6.6.1 Salvavidas Pharmaceutical Corporation Information
6.6.2 Salvavidas Pharmaceutical Description and Business Overview
6.6.3 Salvavidas Pharmaceutical Cabergoline Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Salvavidas Pharmaceutical Product Portfolio
6.6.5 Salvavidas Pharmaceutical Recent Developments/Updates

7 Cabergoline Manufacturing Cost Analysis
7.1 Cabergoline Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cabergoline
7.4 Cabergoline Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cabergoline Distributors List
8.3 Cabergoline Customers

9 Cabergoline Market Dynamics
9.1 Cabergoline Industry Trends
9.2 Cabergoline Growth Drivers
9.3 Cabergoline Market Challenges
9.4 Cabergoline Market Restraints

10 Global Market Forecast
10.1 Cabergoline Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cabergoline by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cabergoline by Type (2022-2027)
10.2 Cabergoline Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cabergoline by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cabergoline by Application (2022-2027)
10.3 Cabergoline Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cabergoline by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cabergoline by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Cabergoline Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Cabergoline Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Cabergoline Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Cabergoline Covered in This Study
Table 5. Global Cabergoline Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Cabergoline Sales Share by Manufacturers (2016-2021)
Table 7. Global Cabergoline Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Cabergoline Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Cabergoline Average Price (US$/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Cabergoline Manufacturing Sites and Area Served
Table 11. Manufacturers Cabergoline Product Type
Table 12. Global Cabergoline Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cabergoline by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cabergoline as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cabergoline Sales by Region (2016-2021) & (Kg)
Table 16. Global Cabergoline Sales Market Share by Region (2016-2021)
Table 17. Global Cabergoline Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Cabergoline Sales by Country (2016-2021) & (Kg)
Table 19. North America Cabergoline Sales Market Share by Country (2016-2021)
Table 20. North America Cabergoline Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Cabergoline Revenue Market Share by Country (2016-2021)
Table 22. Europe Cabergoline Sales by Country (2016-2021) & (Kg)
Table 23. Europe Cabergoline Sales Market Share by Country (2016-2021)
Table 24. Europe Cabergoline Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Cabergoline Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Cabergoline Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Cabergoline Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Cabergoline Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Cabergoline Revenue Market Share by Region (2016-2021)
Table 30. Latin America Cabergoline Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Cabergoline Sales Market Share by Country (2016-2021)
Table 32. Latin America Cabergoline Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Cabergoline Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Cabergoline Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Cabergoline Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Cabergoline Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Cabergoline Revenue Market Share by Country (2016-2021)
Table 38. Global Cabergoline Sales (Kg) by Type (2016-2021)
Table 39. Global Cabergoline Sales Market Share by Type (2016-2021)
Table 40. Global Cabergoline Revenue (Million US$) by Type (2016-2021)
Table 41. Global Cabergoline Revenue Share by Type (2016-2021)
Table 42. Global Cabergoline Price (US$/Kg) by Type (2016-2021)
Table 43. Global Cabergoline Sales (Kg) by Application (2016-2021)
Table 44. Global Cabergoline Sales Market Share by Application (2016-2021)
Table 45. Global Cabergoline Revenue (Million US$) by Application (2016-2021)
Table 46. Global Cabergoline Revenue Share by Application (2016-2021)
Table 47. Global Cabergoline Price (US$/Kg) by Application (2016-2021)
Table 48. Teva API Corporation Information
Table 49. Teva API Description and Business Overview
Table 50. Teva API Cabergoline Sales (Kg), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 51. Teva API Cabergoline Product
Table 52. Teva API Recent Developments/Updates
Table 53. Finetech Pharma Corporation Information
Table 54. Finetech Pharma Description and Business Overview
Table 55. Finetech Pharma Cabergoline Sales (Kg), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 56. Finetech Pharma Cabergoline Product
Table 57. Finetech Pharma Recent Developments/Updates
Table 58. Global Biologicals Corporation Information
Table 59. Global Biologicals Description and Business Overview
Table 60. Global Biologicals Cabergoline Sales (Kg), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 61. Global Biologicals Cabergoline Product
Table 62. Global Biologicals Recent Developments/Updates
Table 63. Wellona Pharma Corporation Information
Table 64. Wellona Pharma Description and Business Overview
Table 65. Wellona Pharma Cabergoline Sales (Kg), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 66. Wellona Pharma Cabergoline Product
Table 67. Wellona Pharma Recent Developments/Updates
Table 68. Alven Laboratories Corporation Information
Table 69. Alven Laboratories Description and Business Overview
Table 70. Alven Laboratories Cabergoline Sales (Kg), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 71. Alven Laboratories Cabergoline Product
Table 72. Alven Laboratories Recent Developments/Updates
Table 73. Salvavidas Pharmaceutical Corporation Information
Table 74. Salvavidas Pharmaceutical Description and Business Overview
Table 75. Salvavidas Pharmaceutical Cabergoline Sales (Kg), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 76. Salvavidas Pharmaceutical Cabergoline Product
Table 77. Salvavidas Pharmaceutical Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Cabergoline Distributors List
Table 81. Cabergoline Customers List
Table 82. Cabergoline Market Trends
Table 83. Cabergoline Growth Drivers
Table 84. Cabergoline Market Restraints
Table 85. Global Cabergoline Sales Forecast by Type (2022-2027) & (Kg)
Table 86. Global Cabergoline Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Cabergoline Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Cabergoline Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Cabergoline Sales Forecast by Application (2022-2027) & (Kg)
Table 90. Global Cabergoline Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Cabergoline Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Cabergoline Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Cabergoline Sales Forecast by Region (2022-2027) & (Kg)
Table 94. Global Cabergoline Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Cabergoline Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Cabergoline Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cabergoline
Figure 2. Global Cabergoline Market Share by Type in 2020 & 2027
Figure 3. Purity < 95% Product Picture
Figure 4. Purity 95%-98% Product Picture
Figure 5. Purity > 98% Product Picture
Figure 6. Global Cabergoline Market Share by Application in 2020 & 2027
Figure 7. Anti-Parkinson
Figure 8. Hyperprolactinemic Disorders
Figure 9. Others
Figure 10. Global Cabergoline Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cabergoline Market Size 2016-2027 (US$ Million)
Figure 12. Global Cabergoline Sales 2016-2027 (Kg)
Figure 13. Global Cabergoline Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Cabergoline Sales Share by Manufacturers in 2020
Figure 15. Global Cabergoline Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Cabergoline Players: Market Share by Revenue in 2020
Figure 17. Cabergoline Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Cabergoline Sales Market Share by Region (2016-2021)
Figure 19. Global Cabergoline Sales Market Share by Region in 2020
Figure 20. Global Cabergoline Revenue Market Share by Region (2016-2021)
Figure 21. Global Cabergoline Revenue Market Share by Region in 2020
Figure 22. U.S. Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Cabergoline Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Cabergoline by Type (2016-2021)
Figure 47. Sales Market Share of Cabergoline by Application (2016-2021)
Figure 48. Sales Market Share of Cabergoline by Application in 2020
Figure 49. Revenue Share of Cabergoline by Application (2016-2021)
Figure 50. Revenue Share of Cabergoline by Application in 2020
Figure 51. Manufacturing Cost Structure of Cabergoline
Figure 52. Manufacturing Process Analysis of Cabergoline
Figure 53. Cabergoline Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’